Postoperative Opioid-Induced Respiratory Depression

1. Airway and breathing: Stimulate the patient (sternal rub), call for help (charge nurse), and position to open airway (head tilt-chin lift or jaw thrust if needed). Apply supplemental oxygen (e.g., 2-4 L/min via nasal cannula) to maintain SpO2 ≥ 90%. Rationale: Opioid-induced respiratory depression is the immediate life threat; hypoxia can quickly lead to cardiac arrest.
2. Stop opioid delivery: Pause the PCA pump and disconnect or clamp the tubing to prevent further morphine administration. Rationale: Removing the offending agent is critical; morphine has a long half-life (2-4 hours) and continued dosing worsens depression.
3. Assess ventilation and circulation: Count respiratory rate, assess depth, check SpO2 continuously, and monitor HR and BP. Obtain a full set of vital signs. Rationale: Hypoventilation may cause hypercapnia and acidosis, leading to bradycardia and hypotension.
4. Prepare to administer naloxone: If respiratory rate remains <8/min or SpO2 <90% despite stimulation and oxygen, administer naloxone 0.04-0.08 mg IV titrated every 2 minutes until respiratory rate >8/min and SpO2 >90%. Rationale: Naloxone reverses opioid effects but can precipitate withdrawal and pain; low-dose titration is safer in opioid-tolerant patients. Be prepared to support ventilation with bag-valve-mask if needed.
5. Call for additional help: Activate rapid response team (RRT) if no improvement or if naloxone is needed. Notify the anesthesiologist or covering physician (since surgeon is unavailable). Rationale: Early escalation is essential for patient safety.
6. Monitor and reassess: Continuous monitoring of respiratory status, sedation level, and pain. Document all interventions and responses. Rationale: Naloxone has a shorter half-life than morphine, so respiratory depression can recur; monitoring for at least 2 hours after the last dose is necessary.

Risk factors: 1) Opioid naivety? Not specified, but PCA morphine can cause dose-related respiratory depression. 2) Obstructive sleep apnea (OSA): Undiagnosed or untreated OSA increases sensitivity to opioids and risk of respiratory depression. The patient did not have his CPAP, which likely worsened airway obstruction during sleep. 3) Concurrent use of sedatives? Not mentioned, but if any were given, they would potentiate depression. 4) Age and weight: 58 years, 80 kg (not obese, but OSA is a key factor). 5) PCA modality: Continuous or demand-only? Here it's demand-only (bolus with lockout), but total dose 18 mg in 4 hours is within limit but still may be excessive for this patient.

Prevention strategies: 1) Risk assessment: Use a validated tool (e.g., STOP-BANG) to screen for OSA preoperatively; for known OSA, ensure CPAP is available and used postoperatively. 2) Multimodal analgesia: Reduce opioid use by adding scheduled acetaminophen and NSAIDs (if not contraindicated), and consider regional blocks. 3) PCA settings: Consider lower bolus dose (e.g., 0.5 mg) and longer lockout (e.g., 10 minutes) for patients at high risk. 4) Monitoring: Continuous pulse oximetry and capnography if available; frequent respiratory rate checks (every 1-2 hours) for first 24 hours. 5) Education: Teach patient and family about signs of oversedation and to call nurse if patient is hard to wake. 6) Avoid concomitant sedatives: Minimize benzodiazepines and antihistamines. 7) Early mobilization and positioning: Keep head elevated, encourage deep breathing. 8) Documentation and communication: Handoff to include OSA status and pain regimen.